24 okt: Schering: Undersøgelsesresultat vedr. tidlig MS offentlig...
24 okt: Fabricius og Kastholms møbelklassikere
24-10-2006 11:39:00

Hugin Ad hoc announcement according to § 15 WpHG: Misc. business figure: STRATEC Biomedical Systems AG: STRATEC clearly exceeds earnings for overall previous year after only nine months

Birkenfeld, October 24, 2006

The Board of Management of STRATEC Biomedical Systems AG, which is

listed in the Prime Standard and Gate-M indices, hereby announces the

preliminary, unaudited consolidated figures based on IFRS

(International Financial Reporting Standards) of the STRATEC Group

for the first nine months of the 2006 financial year pursuant to

Section 15 of the German Securities Trading Act (WpHG).

+-------------------------------------------------------------------+

| Key Figures (EUR | 01.01.- | 01.01.- | Change |

| 000s) | 09.30.2006 | 09.30.2005 | |

|---------------------+-----------------+-----------------+---------|

| Sales | 51,933 | 33,945 | + 53.0% |

|---------------------+-----------------+-----------------+---------|

| Gross performance | 51,887 | 35,582 | + 45.8% |

|---------------------+-----------------+-----------------+---------|

| EBITDA | 8,295 | 5,315 | + 56.1% |

|---------------------+-----------------+-----------------+---------|

| EBIT | 7,199 | 4,587 | + 56.9% |

|---------------------+-----------------+-----------------+---------|

| EBT | 7,097 | 4,409 | + 61.0% |

|---------------------+-----------------+-----------------+---------|

| Consolidated net | 5,304 | 2,895 | + 83.2% |

| income | | | |

|---------------------+-----------------+-----------------+---------|

| Earnings per share | 0.48 | 0.29 | + 65.5% |

| (EUR) | | | |

+-------------------------------------------------------------------+

The STRATEC Group had a total of 215 employees as of

September 30, 2006 (previous year: 189).

Information and disclosures concerning this ad-hoc announcement:

Irrespective of possible new levels of sales and earnings correlating

with the market launch of new analyzer system families, the company

assumes that the seasonal fluctuations witnessed in sales and

earnings in the past will be increasingly countered by logistical

measures involving procurement and production.

In the past 2005 financial year, the STRATEC Group had an average of

191 employees and generated sales of Euro 47.3 million, earnings

before tax (EBT) of Euro 6.9 million and consolidated income of Euro

4.4 million, with earnings per share of Euro 0.43 (earnings for

overall previous year).

The extensive interim report will be available on our internet page

as a download from around 3 p.m. on November 8, 2006.

Based on current budgeting, the growth forecast for the company will

be reflected in particular from the second and third quarter of the

2007 financial year onwards.

About STRATEC

STRATEC Biomedical Systems AG (http://www.stratec-biomedical.de)

designs and manufactures fully automated systems for its partners in

the fields of clinical diagnostics and biotechnology. These partners

market such systems, in general together with their own reagents, to

laboratories and research institutes around the world. The company

develops its products on the basis of its own patented technologies.

Shares in the company (SIN: 728900 / ISIN: DE0007289001) are traded

in the Prime Standard segment of the Frankfurt Stock Exchange, in the

Gate-M trading segment of the Stuttgart Stock Exchange and on other

exchanges.

The STRATEC Group comprises the listed holding company "STRATEC

Biomedical Systems AG", as well as the subsidiaries "STRATEC NewGen",

"Robion" and "Sanguin".

Further information can be obtained from:

STRATEC Biomedical Systems AG

André Loy, Investor Relations

Gewerbestrasse 37, 75217 Birkenfeld

Germany

Tel: +49 7082 7916-190

Fax: +49 7082 7916-999

E-Mail: ir@stratec-biomedical.de

--- End of Ad-hoc Message ---

WKN: 728900; ISIN: DE0007289001;

Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Gate-M in

Börse Stuttgart,

Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse

München,

Freiverkehr in Börse Düsseldorf;

Copyright © Hugin ASA . All rights reserved.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
14 dec
GEN
Genmab kom sent fredag med en fondbørsmeddelse om en milestone på $3 milloner vedrørende deres DuoBo..
30
12 dec
OW
  Mange danske har nok set DR’s dokumentar udsendelser om, hvad der skete med mange af de tidligere ..
18
14 dec
VWS
Lomborg ved udmærket godt han er på gyngende grund, i mange af hans påstande.   Den værste er, når h..
16
13 dec
VWS
Nu kører vi/Vestas den sidste måned af Q4-2014, og aktiviteten er øget måned efter måned igennem 201..
16
14 dec
MAERSK-B
Husk nu at en produktions nedgang på små 500000 tønder om dagen kan få prisen til at stige markant m..
12
15 dec
GEN
Genmab har afholdt bestyrelsesmøde og valgt at give bestyrelse, direktion og ledende medarbejdere op..
11
14 dec
VWS
Der fik du godt nok sat alle verdens videnskabsfolk på plads! Rundt regnet 98% af alle de kloge, ans..
11
11 dec
 
Til dem af jer der shorter nordiske olie-aktier så er her shorting status på alle dem jeg har adgang..
10
12 dec
VWS
Interessant lille citat   "Netop nu knokler -ansatte på livet løs i det, der er vindmøllegigantens t..
9
17 dec
VWS
Det er meget interessant at Goldman Sachs øger sit target. Igår faldt Vestas 5 % alt imens et af ..
8

Novozymes vil ind på markedet for probiotika til foder - avis

17-12-2014 16:03:21
Novozymes har planer om at gøre sin entre på markedet for probiotika til dyrefoder, som selskabet ser gode muligheder i. Håbet er, at landbruget med tiden tager..

Bayer indsender FDA-registreringsansøgning for bløderprodukt

17-12-2014 14:05:05
Den tyske virksomhed Bayer Healthcare har indsendt registreringsansøgning for lægemiddelkandidaten BAY 81-8973 til behandling af blødersygdommen Hæmofili A hos ..

Aktier/middag: Syv dages nedtur afløst af nervøse plusser

17-12-2014 11:32:52
Efter syv handelsdage i streg ser det danske aktiemarked ud til at have ramt sin foreløbige bund, og onsdag formiddag går det således atter let fremad for de da..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas: USA's senat godkender PTC-forlængelse
2
Aktier/tendens: Carlsberg og Vestas i fokus i nervøst marked
3
Ruslands regering sælger aktiver for at støtte rubel - NY
4
Direktør fyres for at give penge til håndboldklub
5
Aktier/middag: Syv dages nedtur afløst af nervøse plusser

Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. december 2014 03:22:42
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141211.1 - EUROWEB5 - 2014-12-18 03:22:42 - 2014-12-18 03:22:42 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x